Replimune Group, Inc.
REPL
$8.02
$0.040.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 103.96M | 103.23M | 92.29M | 74.11M | 64.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 324.22M | 318.34M | 292.93M | 259.86M | 239.17M |
| Operating Income | -324.22M | -318.34M | -292.93M | -259.86M | -239.17M |
| Income Before Tax | -315.27M | -309.80M | -279.75M | -246.83M | -227.73M |
| Income Tax Expenses | -418.00K | 468.00K | 468.00K | 468.00K | 510.00K |
| Earnings from Continuing Operations | -314.85 | -310.26 | -280.22 | -247.30 | -228.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -314.85M | -310.26M | -280.22M | -247.30M | -228.24M |
| EBIT | -324.22M | -318.34M | -292.93M | -259.86M | -239.17M |
| EBITDA | -317.06M | -311.13M | -285.34M | -252.11M | -231.96M |
| EPS Basic | -3.44 | -3.46 | -3.23 | -3.07 | -3.08 |
| Normalized Basic EPS | -2.15 | -2.16 | -2.02 | -1.92 | -1.92 |
| EPS Diluted | -3.44 | -3.46 | -3.23 | -3.07 | -3.08 |
| Normalized Diluted EPS | -2.15 | -2.16 | -2.02 | -1.92 | -1.92 |
| Average Basic Shares Outstanding | 366.54M | 357.85M | 344.50M | 321.29M | 297.06M |
| Average Diluted Shares Outstanding | 366.54M | 357.85M | 344.50M | 321.29M | 297.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |